DEXYCU SIDE EFFECTS
- Generic Name: dexamethasone intraocular suspension 9%, for intraocular administration
- Brand Name: Dexycu
The following adverse reactions are described elsewhere in the labeling:
- Increase in Intraocular Pressure.
- Delayed Healing.
- Infection Exacerbation.
- Cataract Progression.
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The following adverse events rates are derived from three clinical trials in which 339 patients received the 517 microgram dose of DEXYCU. The most commonly reported adverse reactions occurred in 5-15% of subjects and included increases in intraocular pressure, corneal edema and iritis. Other ocular adverse reactions occurring in 1-5% of subjects included, corneal endothelial cell loss, blepharitis, eye pain, cystoid macular edema, dry eye, ocular inflammation, posterior capsule opacification, blurred vision, reduced visual acuity, vitreous floaters, foreign body sensation, photophobia, and vitreous detachment.
SRC: NLM .